Skip to main navigation

Top Bar Nav

Contact Us

Social Icons

linkedin twitter

About Nav

About

Medicines Nav

Medicines

Research Nav

Science

Responsibility Nav

Our Purpose

News Nav

News

IR Nav

Investors

Careers Nav

Careers

Home News Press Release Archive

Press Release Archive

News Nav

News
Press Release Archive
Events Archive
Our Stories

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Press Release Archive

Year

Jazz Pharmaceuticals, Inc. Announces Submission of Complete Responses to FDA Approvable Letters for Luvox(R) CR and Luvox(R)

August 2, 2007

Jazz Pharmaceuticals, Inc. to Announce Second Quarter 2007 Financial Results on August 9, 2007

July 26, 2007

Jazz Pharmaceuticals Announces Settlement of Government Investigation

July 13, 2007

Jazz Pharmaceuticals, Inc. Announces Initial Public Offering

May 31, 2007

JAZZ PHARMACEUTICALS LAUNCHES SLEEP MEDICINE FELLOWSHIP GRANT PROGRAM

March 26, 2007

JAZZ PHARMACEUTICALS SUPPORTS NARCOLEPSY NETWORK INITIATIVE TO LAUNCH THE NATIONAL NARCOLEPSY AWARENESS CAMPAIGN

March 5, 2007

JAZZ PHARMACEUTICALS, INC. AND SOLVAY PHARMACEUTICALS, INC. ANNOUNCE LICENSE AGREEMENT FOR LUVOX® (FLUVOXAMINE MALEATE) TABLETS AND FLUVOXAMINE MALEATE EXTENDED-RELEASE CAPSULES IN THE UNITED STATES

February 1, 2007

Pagination

First page
Previous page
…
Page 44
Page 45
Page 46
Page 47
Page 48
Page 49
Page 50
Page 51
Current page 52

Displaying 511 - 517 of 517

About Nav

About

Medicines Nav

Medicines

Research Nav

Science

Responsibility Nav

Our Purpose

IR Nav

Investors

© 2023 Jazz Pharmaceuticals plc All Rights Reserved.

Legal Nav

Privacy Statement
Terms of Use
Social Media Global Guidelines
Cookie Policy
Sitemap